Thresholds for the cost–effectiveness of interventions: alternative approaches
暂无分享,去创建一个
Sydney Rosen | Bruce Larson | Elliot Marseille | James G Kahn | D. Kazi | E. Marseille | J. Kahn | Dhruv S Kazi | Dhruv S. Kazi | B. Larson | S. Rosen
[1] P. Moszynski. Global Fund suspends new projects until 2014 because of lack of funding , 2011, BMJ : British Medical Journal.
[2] A Gafni,et al. Opportunity costs and uncertainty in the economic evaluation of health care interventions. , 2002, Health economics.
[3] A. Garber,et al. Economic foundations of cost-effectiveness analysis. , 1997, Journal of health economics.
[4] Sarah C Leeper,et al. United States global health policy: HIV/AIDS, maternal and child health, and The President's Emergency Plan for AIDS Relief (PEPFAR) , 2010, AIDS.
[5] K. Kawai,et al. Estimated health and economic impact of quadrivalent HPV (types 6/11/16/18) vaccination in Brazil using a transmission dynamic model , 2012, BMC Infectious Diseases.
[6] Karla Hemming,et al. Sample size calculations for cluster randomised controlled trials with a fixed number of clusters , 2011, BMC medical research methodology.
[7] Anthony J. Culyer,et al. Cost-effectiveness Analysis Registry , 2014 .
[8] M Johannesson,et al. Some reflections on cost-effectiveness analysis. , 1998, Health economics.
[9] J. Stringer,et al. Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia , 2012, PloS one.
[10] D M Eddy,et al. Clinical decision making: from theory to practice. Cost-effectiveness analysis. Is it up to the task? , 1992, JAMA.
[11] Martin J. Aryee,et al. Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review , 2012, BMC Public Health.
[12] J. Mauskopf,et al. Cost-effectiveness league tables: valuable guidance for decision makers? , 2003, PharmacoEconomics.
[13] R. Robinson. Economic Evaluation and Health Care Cost-effectiveness analysis , 2006 .
[14] W. Gerth,et al. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[15] C. I. Jones,et al. The Value of Life and the Rise in Health Spending , 2004 .
[16] J. Ioannidis,et al. Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment , 2013, BMJ : British Medical Journal.
[17] T. Edejer,et al. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector , 2003, Cost effectiveness and resource allocation : C/E.
[18] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[19] M. Drummond,et al. Cost-effectiveness league tables: more harm than good? , 1993, Social science & medicine.
[20] David Moher,et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement , 2013, International Journal of Technology Assessment in Health Care.
[21] T. Clasen,et al. Cost of Community Integrated Prevention Campaign for Malaria, HIV, and Diarrhea in Rural Kenya , 2011, BMC health services research.
[22] Kristian Thorlund,et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? , 2009, International journal of epidemiology.
[23] L. Weinehall,et al. Cost-effectiveness analysis with defined budget: how to distribute resources for the prevention of cardiovascular disease? , 1999, Health policy.
[24] Michael E. Chernew,et al. Willingness to Pay for a Quality-adjusted Life Year , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.
[25] L. Newman,et al. The Cost and Cost-Effectiveness of Scaling up Screening and Treatment of Syphilis in Pregnancy: A Model , 2014, PloS one.
[26] M. Drummond,et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement , 2013, BJOG : an international journal of obstetrics and gynaecology.
[27] T. Clasen,et al. Cost-effectiveness of water quality interventions for preventing diarrhoeal disease in developing countries. , 2007, Journal of water and health.
[28] Peter A Ubel,et al. What is the price of life and why doesn't it increase at the rate of inflation? , 2003, Archives of internal medicine.
[29] A. Galvani,et al. Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania. , 2009, Vaccine.
[30] N. Bristol. Slow going for the global health initiative. , 2011, Health affairs.
[31] C. Roelofs. Prevention effectiveness: A guide to decision analysis and economic evaluation , 1997 .
[32] P. Taylor. Clinical Decision Making: From Theory to Practice , 1996 .
[33] J. Lave,et al. Willingness to Pay for a Quality-Adjusted Life Year: Implications for Societal Health Care Resource Allocation , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.
[34] David O. Meltzer,et al. Editorial: Some reflections on cost‐effectiveness analysis , 1998 .
[35] A. Gulland. Global Fund needs $15bn to fight HIV, tuberculosis, and malaria , 2013, BMJ : British Medical Journal.
[36] Richard J. Zeckhauser,et al. Critical ratios and efficient allocation , 1973 .
[37] P. Moszynski. Progress in global access to medicines threatened by funding shortfalls, warns charity , 2011, BMJ : British Medical Journal.
[38] Guilbert Jj. The world health report 2002 - reducing risks, promoting healthy life. , 2003 .
[39] Grazyna Adamiak,et al. Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .
[40] R. Baltussen,et al. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries , 2005, BMJ : British Medical Journal.
[41] A. Boardman,et al. Cost-Benefit Analysis: Concepts and Practice , 1996 .